Your test, explained
5 min readDHEA-S Blood Test: The Ultimate Adrenal Androgen Biomarker
A precise quantitative measurement of Dehydroepiandrosterone Sulfate (DHEA-S) in the serum. It serves as the gold-standard biomarker for evaluating adrenal androgen output, investigating female virilization, and phenotyping Polycystic Ovary Syndrome (PCOS).
Your options, side by side
Compare retailer prices.
Find a listing that fits your needs. Review the details, then order with the retailer.
No retailer listings yet.
Read the test guide or explore other tests in the directory.
Explore testsPrices shown are listed test prices, not checkout totals. Expand a listing for supplied fees and its observation date. Check included measurements, collection requirements, and the performing lab before ordering.
Understand before you decide
The test, explained.
Overview
In clinical endocrinology, if you want to understand the output of the adrenal glands, you do not just measure cortisol. You must measure Dehydroepiandrosterone Sulfate (DHEA-S), the most abundant circulating steroid hormone in the human body.
As a senior clinical endocrinologist and laboratory diagnostician, I utilize the DHEA-S blood test as the definitive marker for the adrenal cortex (specifically the zona reticularis). Unlike unconjugated DHEA, which fluctuates wildly throughout the day based on acute stress and diurnal rhythms, DHEA-S has a sulfate molecule attached. This sulfation drastically slows its clearance from the blood, giving it a stable half-life of 10 to 20 hours. This makes DHEA-S the ultimate, highly reliable 'snapshot' of your baseline adrenal androgen production. It is the cornerstone test for differentiating whether a hormonal imbalance (like PCOS or severe acne) is originating from the ovaries or the adrenal glands.
About this test
Advanced Clinical Diagnostic Utility of DHEA-S
To extract genuine clinical utility from this endocrine panel, one must understand that DHEA-S acts as a massive metabolic reservoir. It is a prohormone that peripheral tissues actively convert into active testosterone and estrogens as needed.
1. The Ovarian vs. Adrenal Differential Diagnosis
Locating the Source: When a female patient presents with hyperandrogenism (severe cystic acne, facial hair, male-pattern hair thinning), we must determine where the excess male hormones are coming from. The ovaries produce testosterone, but they produce almost zero DHEA-S. The adrenal glands produce 100% of the body's DHEA-S. Therefore, if a woman has high Testosterone but normal DHEA-S, the issue is ovarian (classic PCOS). If her DHEA-S is sky-high, the issue is adrenal (Adrenal PCOS phenotype, Congenital Adrenal Hyperplasia, or an adrenal mass).
2. The Anti-Aging and Neurosteroid Axis
The Age-Related Decline: DHEA-S production peaks between the ages of 20 and 25 and then undergoes a profound, steady decline—dropping by roughly 10% to 20% every decade. By age 70, levels are often only 20% of their peak. Because DHEA-S acts as a potent neurosteroid in the brain, mitigating cortisol-induced neurotoxicity, tracking and optimizing its age-related decline is a primary focus in advanced functional medicine and cognitive preservation protocols.
3. The Cortisol to DHEA-S Ratio
The Stress Resilience Metric: Cortisol breaks tissue down (catabolic), while DHEA-S builds it up (anabolic). In early-stage chronic stress, both rise. However, in late-stage severe HPA-axis dysfunction (often colloquially called 'adrenal fatigue'), the adrenal glands experience a 'pregnenolone steal' effect, shunting all raw materials to produce cortisol to keep you alive, while DHEA-S production collapses. A high Cortisol-to-DHEA-S ratio is a definitive laboratory marker of profound systemic exhaustion and immune suppression.
When to discuss this test
You should prioritize this targeted endocrine evaluation when:
- You are a female experiencing rapid-onset virilization (deepening voice, clitoromegaly, severe hirsutism), which demands immediate ruling out of an androgen-secreting adrenal tumor.
- You have been diagnosed with PCOS but are not responding to standard insulin-sensitizing therapies (like Metformin), indicating you likely have the Adrenal PCOS phenotype.
- You suffer from profound, unexplained chronic fatigue, severe joint aches, and loss of libido, indicating a potential collapse of adrenal androgen output.
- You are monitoring the efficacy of prescribed DHEA replacement therapy in autoimmune or adrenal insufficiency conditions.
Who may benefit
This test is an absolute necessity for reproductive endocrinologists phenotyping complex infertility, pediatricians evaluating precocious (early) puberty in children, functional medicine practitioners reversing severe HPA-axis dysregulation, and anti-aging specialists titrating hormone optimization protocols.
How this test is used
- Adrenal-Phenotype Polycystic Ovary Syndrome (PCOS)
- Congenital Adrenal Hyperplasia (CAH - e.g., 21-hydroxylase deficiency)
- Adrenal Carcinoma or Adenoma
- Age-Related Adrenal Decline (Adrenopause)
Before your appointment
Plan your visit.
- Fasting
- Follow retailer guidance
- Collection timing
- Morning collection preferred
How to prepare
- Strict Fasting (8 Hours): While conventional, lower-tier laboratory manuals state fasting is 'not required' because DHEA-S does not have a strict diurnal rhythm, this is a clinical oversight for immunoassay accuracy. Postprandial lipemia (triglycerides circulating after a meal) heavily interferes with the optical clarity required for the Electrochemiluminescence Immunoassay (ECLIA). An 8-hour fast guarantees a pristine, uncorrupted baseline. Water is permitted.
- Biotin Washout (72 Hours): The DHEA-S immunoassay utilizes a streptavidin-biotin binding mechanism. If you are taking high-dose Biotin (Vitamin B7) for hair, skin, and nails (which many PCOS patients do), it will severely interfere with the assay, causing a falsely elevated result. You must stop all biotin-containing supplements 72 hours before the draw.
- Supplement Protocol: If you are taking over-the-counter DHEA supplements, you must discuss your testing goal with your provider. If testing to see your natural baseline, stop the supplement for 7 days prior. If testing to monitor your dosage efficacy, take your dose as normal and note the time of ingestion.
Important considerations
The Age-Adjusted Reference Trap: Because DHEA-S plummets naturally with age, standard laboratory reference ranges are aggressively age-adjusted. A DHEA-S level of 60 mcg/dL might be flagged as 'normal' for a 65-year-old female on a standard lab report. However, in advanced functional endocrinology, we recognize that while this level is 'average' for a sick, aging population, it is functionally deficient for optimal immune and cognitive health. Always interpret results functionally, not just statistically.
Follow the instructions from your retailer and clinician. Information on this page is educational and does not replace individual medical advice.
See what to expect
Sample reports & resources.
Published examples and supporting files for this test.
No sample files are published for this test yet.
Looking for your own results? Open your reports dashboard
For a closer look
Sources & further reading.
Further reading
Recent Clinical Breakthroughs (2024-2026):
- DHEA-S and Long-COVID Resilience: A landmark 2024 study published in Psychoneuroendocrinology demonstrated that patients with a healthy, robust Cortisol-to-DHEA-S ratio were 70% less likely to develop severe Post-Acute Sequelae of SARS-CoV-2 (Long-COVID). DHEA-S was proven to possess powerful immunomodulatory properties, specifically preventing the hyper-activation of pro-inflammatory cytokines that cause persistent neurological brain fog.
- Phenotyping Adrenal PCOS: 2025 guidelines from the Endocrine Society heavily emphasize utilizing DHEA-S to formally classify 'Adrenal PCOS.' Research revealed that roughly 25% of all PCOS patients have primarily adrenal-driven androgen excess. These patients do not respond to ovarian-targeted therapies (like birth control or Spironolactone) but require specialized interventions targeting HPA-axis down-regulation and stress reduction.
- Cognitive Preservation in Aging: A 2026 longitudinal cohort in the Journal of Clinical Endocrinology & Metabolism definitively linked higher quartile DHEA-S levels in adults over 60 with a significantly slower rate of hippocampal atrophy and preservation of executive function, validating DHEA-S replacement therapy as a frontline neuroprotective intervention in early-stage cognitive decline.
Sources
- Psychoneuroendocrinology (2024). "The Cortisol/DHEA-S Ratio as a Predictive Biomarker for Neuro-Inflammatory Persistence in Long-COVID Syndrome."
- Journal of Clinical Endocrinology & Metabolism (2025). "Redefining Polycystic Ovary Syndrome: The Clinical Mandate for DHEA-S in Identifying the Adrenal Phenotype."
- Journal of Clinical Endocrinology & Metabolism (2026). "Longitudinal DHEA-S Trajectories and Hippocampal Preservation: Neuroprotective Mechanisms in Aging Populations."
